News 24 Feb 2026 Rznomics and GluGene Therapeutics Partner to Develop Next-Generation RNA Gene Therapies Rznomics, a leader in RNA-based gene therapeutics, and GluGene Therapeutics, an innovator in Adeno-Associated Virus (AAV) vector engineering, have entered… GluGene
